Palatin Techs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Palatin Techs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Palatin Techs Analyst Ratings
HC Wainwright & Co. : The Palatin Techs (PTN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $17.00.
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
HC Wainwright & Co. : The Palatin Techs (PTN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $17.00.
Palatin Techs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)
Palatin Techs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Buy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment Advancements
Buy Rating Affirmed for Palatin Technologies Following Successful Phase 3 Trial of PL9643 for Dry Eye Disease
Maintained Buy Rating on Palatin Technologies Amid Promising Clinical Results and Future Prospects
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)
Buy Rating Affirmed on Palatin Technologies for Promising Pipeline and Strategic Market Positioning
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $70 Price Target